Literature DB >> 11573705

Spontaneous episode of polymorphic ventricular tachycardia in a patient with intermittent Brugada syndrome.

J C Geller1, S Reek, A Goette, H U Klein.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11573705     DOI： 10.1046/j.1540-8167.2001.01094.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  8 in total

Review 1.  J wave syndromes.

Authors:  Charles Antzelevitch; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2009-12-11       Impact factor: 6.343

2.  A gain-of-function I(K-ATP) mutation and its role in sudden cardiac death associated with J-wave syndromes.

Authors:  Charles Antzelevitch; Hector Barajas-Martinez
Journal:  Heart Rhythm       Date:  2010-08-22       Impact factor: 6.343

3.  J-wave syndromes. from cell to bedside.

Authors:  Charles Antzelevitch; Gan-Xin Yan
Journal:  J Electrocardiol       Date:  2011-09-09       Impact factor: 1.438

Review 4.  Genetic, molecular and cellular mechanisms underlying the J wave syndromes.

Authors:  Charles Antzelevitch
Journal:  Circ J       Date:  2012-04-11       Impact factor: 2.993

5.  Rationale for the use of the terms J-wave syndromes and early repolarization.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Sami Viskin
Journal:  J Am Coll Cardiol       Date:  2011-04-12       Impact factor: 24.094

6.  Overview of Basic Mechanisms of Cardiac Arrhythmia.

Authors:  Charles Antzelevitch; Alexander Burashnikov
Journal:  Card Electrophysiol Clin       Date:  2011-03-01

Review 7.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

8.  Mode of onset of ventricular fibrillation in patients with early repolarization pattern vs. Brugada syndrome.

Authors:  Gi-Byoung Nam; Kwan-Ho Ko; Jun Kim; Kyoung-Min Park; Kyoung-Suk Rhee; Kee-Joon Choi; You-Ho Kim; Charles Antzelevitch
Journal:  Eur Heart J       Date:  2009-10-29       Impact factor: 29.983
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.